BCCIP antibody (AA 181-273)
Quick Overview for BCCIP antibody (AA 181-273) (ABIN1833762)
Target
See all BCCIP AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 181-273
-
Specificity
- Human BCCIP
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide corresponding to a region within amino acids 181 and 273 of BCCIP (SwissProt Q9P287).
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
- Approved: ICC (1:100 - 1:1000), IHC, IHC-P (1:100 - 1:1000), WB (1:500 - 1:3000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.1 M Tris-glycine, pH 7.0, 10 % glycerol, 0.01 % Thimerosal
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Keep as concentrated solution. Avoid multiple freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- BCCIP (BRCA2 and CDKN1A Interacting Protein (BCCIP))
-
Alternative Name
- BCCIP
-
Background
-
Name/Gene ID: BCCIP
Synonyms: BCCIP, BCCIPbeta, TOK-1alpha, TOK1, TOK-1, Protein TOK-1, BCCIPalpha, TOK-1beta -
Gene ID
- 56647
-
UniProt
- Q9P287
Target
-